<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635788"><TermName>EPOCH regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat aggressive forms of non-Hodgkin lymphoma, including mantle cell lymphoma. It includes the drugs etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, and doxorubicin hydrochloride (hydroxydaunorubicin). Also called EPOCH.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722866" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;EPOCH regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722865" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen EPOCH&quot;" language="es" id="_4"/><SpanishTermName>régimen EPOCH</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de  una quimioterapia combinada que se usa para tratar las formas dinámicas del linfoma no Hodgkin, incluso el linfoma de células del manto. Contiene los medicamentos fosfato de etopósido, prednisona, sulfato de vincristina (Oncovin), ciclofosfamida y clorhidrato de doxorubicina (hidroxidaunorubicina).   También se llama EPOCH.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-23</DateFirstPublished><DateLastModified>2010-05-05</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000634872">EPOCH</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
